Quality of life during 5 years after stereotactic radiotherapy in stage I non-small cell lung cancer

Radiation Oncology

Volumn 10, Issue 1, 2015, Pages

  Ubels, Rutger J ^a   Mokhles, Sahar ^b   Andrinopoulou, Eleni R ^b   Braat, Cornelia ^a   van der Voort van Zyp, Noëlle C ^a   Aluwini, Shafak ^a   Aerts, Joachim G ^a   Nuyttens, Joost J ^a  

^a ERASMUS MC CANCER INSTITUTE   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; COUGHING; DYSPNEA; EMOTIONALITY; ESOPHAGUS PAIN; FATIGUE; FOLLOW UP; HUMAN; LONG TERM CARE; NON SMALL CELL LUNG CANCER; OVERALL SURVIVAL; PATIENT MONITORING; PHYSICAL ACTIVITY; QUALITY OF LIFE; SELF REPORT; STEREOTACTIC TREATMENT; THORAX PAIN; CARCINOMA, NON-SMALL-CELL LUNG; CLINICAL TRIAL; COUGH; DAILY LIFE ACTIVITY; EMOTION; FEMALE; HEALTH STATUS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PAIN; PATHOLOGY; PHASE 2 CLINICAL TRIAL; POSTOPERATIVE COMPLICATIONS; PSYCHOLOGY; QUESTIONNAIRE; RADIOSURGERY; ROLE PLAYING; SURVIVAL RATE; SURVIVOR; VERY ELDERLY;

ACTIVITIES OF DAILY LIVING; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; COUGH; DYSPNEA; EMOTIONS; FEMALE; FOLLOW-UP STUDIES; HEALTH STATUS; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PAIN; POSTOPERATIVE COMPLICATIONS; QUALITY OF LIFE; RADIOSURGERY; ROLE; SURVEYS AND QUESTIONNAIRES; SURVIVAL RATE; SURVIVORS;

EID: 84931281850     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/s13014-015-0405-9     Document Type: Article

References (25)

1. Padda SK, Burt BM, Trakul N, Wakelee HA. Early-stage non-small cell lung cancer: surgery, stereotactic radiosurgery, and individualized adjuvant therapy. Semin Oncol. 2014;41:40-56.
2. Videtic GM, Reddy CA, Sorenson L. A prospective study of quality of life including fatigue and pulmonary function after stereotactic body radiotherapy for medically inoperable early-stage lung cancer. Support Care Cancer. 2013;21:211-8.
3. Haasbeek CJ, Lagerwaard FJ, Antonisse ME, Slotman BJ, Senan S. Stage I nonsmall cell lung cancer in patients aged > or =75years: outcomes after stereotactic radiotherapy. Cancer. 2010;116:406-14.
4. Van Zyp NC V d V, Van der Holt B, Van Klaveren RJ, Pattynama P, Maat A, Nuyttens JJ. Stereotactic body radiotherapy using real-time tumor tracking in octogenarians with non-small cell lung cancer. Lung Cancer. 2010;69:296-301.
5. Lagerwaard FJ, Verstegen NE, Haasbeek CJ, Slotman BJ, Paul MA, Smit EF, et al. Outcomes of stereotactic ablative radiotherapy in patients with potentially operable stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2012;83:348-53.
6. Widder J, Postmus D, Ubbels JF, Wiegman EM, Langendijk JA. Survival and quality of life after stereotactic or 3D-conformal radiotherapy for inoperable early-stage lung cancer. Int J Radiat Oncol Biol Phys. 2011;81:e291-7.
7. Van Zyp NC V d V, Prevost JB, Van der Holt B, Braat C, Van Klaveren RJ, Pattynama PM, et al. Quality of life after stereotactic radiotherapy for stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2010;77:31-7.
8. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373-83.
9. Linn BS, Linn MW, Gurel L. Cumulative illness rating scale. J Am Geriatr Soc. 1968;16:622-6.
10. Nuyttens JJ, van de Pol M. The CyberKnife radiosurgery system for lung cancer. Expert Rev Med Devices. 2012;9:465-75.
11. Van Zyp NC V d V, Prevost JB, Hoogeman MS, Praag J, Van der Holt B, Levendag PC, et al. Stereotactic radiotherapy with real-time tumor tracking for non-small cell lung cancer: clinical outcome. Radiother Oncol. 2009;91:296-300.
12. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365-76.
13. Pinheiro JC. Mixed-Effects Models in S and S-Plus. New York: Springer; 2000.
14. Verbeke GMG. Linear Mixed Models for Longitudinal Data. New york: Springer; 2009.
15. Harley DP, Krimsky WS, Sarkar S, Highfield D, Aygun C, Gurses B. Fiducial marker placement using endobronchial ultrasound and navigational bronchoscopy for stereotactic radiosurgery: an alternative strategy. Ann Thorac Surg. 2010;89:368-73.
16. Mathieu D, Campeau MP, Bahig H, Larrivee S, Vu T, Lambert L, et al. Long-term quality of life in early-stage non-small cell lung cancer patients treated with robotic stereotactic ablative radiation therapy. Pract Radiat Oncol. 2015; In Press.
17. Langendijk JA, Aaronson NK, De Jong JM, Ten Velde GP, Muller MJ, Slotman BJ, et al. Quality of life after curative radiotherapy in Stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2002;53:847-53.
18. Langendijk JA, Ten Velde GP, Aaronson NK, De Jong JM, Muller MJ, Wouters EF. Quality of life after palliative radiotherapy in non-small cell lung cancer: a prospective study. Int J Radiat Oncol Biol Phys. 2000;47:149-55.
19. Fletcher C, Peto R. The natural history of chronic airflow obstruction. Br Med J. 1977;1:1645-8.
20. Tantucci C, Modina D. Lung function decline in COPD. Int J Chron Obstruct Pulmon Dis. 2012;7:95-9.
21. Decramer M, Cooper CB. Treatment of COPD: the sooner the better? Thorax. 2010;65:837-41.
22. Carrasco Garrido P, De Miguel Diez J, Rejas Gutierrez J, Centeno AM, Gobartt Vazquez E, Gil De Miguel A, et al. Negative impact of chronic obstructive pulmonary disease on the health-related quality of life of patients. Results of the EPIDEPOC study. Health Qual Life Outcomes. 2006;4:31.
23. Bridevaux PO, Gerbase MW, Probst-Hensch NM, Schindler C, Gaspoz JM, Rochat T. Long-term decline in lung function, utilisation of care and quality of life in modified GOLD stage 1 COPD. Thorax. 2008;63:768-74.
24. Mohan A, Mohan C, Pathak AK, Pandey RM, Guleria R. Impact of chronic obstructive pulmonary disease on respiratory status and quality of life in newly diagnosed patients with lung cancer. Respirology. 2007;12:240-7.
25. Gore JM, Brophy CJ, Greenstone MA. How well do we care for patients with end stage chronic obstructive pulmonary disease (COPD)? A comparison of palliative care and quality of life in COPD and lung cancer. Thorax. 2000;55:1000-6.